Prism Pharmaceuticals, Inc.

Reimbursement risks and unpredictable regulatory paths have had a lingering negative impact on venture investments in medtech companies. This seems particularly true in the medtech-dominant cardiovasc

IN VITRO DIAGNOSTICS Banyan Biomarkers Inc. TBI test maker Banyan Biomarkers raises $6mm in Series A financing Banyan Biomarkers Inc. , which focuses on neurological molecular diagnostics, has

A look at financing, M&A, and alliance activity April-June 2011 In this issue, we present another installment of our quarterly review of device/diagnostics dealmaking – for the second quarter of 2011.

Baxter once again plans to add to its IV solutions business – this time through the acquisition Baxa Corporation for $380 million in cash. Baxa is a privately held company that has developed pharmacy